Bridgeway Capital Management, LLC Landos Biopharma, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.26 - $0.55 $15,600 - $33,000	-60,000 Reduced 60.61%	39,000 $11,000
Q4 2022 Feb 14, 2023	SELL	$0.22 - $0.51 $11,000 - $25,500	-50,000 Reduced 33.56%	99,000 $49,000
Q2 2022 Aug 15, 2022	SELL	$0.6 - $1.5 $6,000 - $15,000	-10,000 Reduced 6.29%	149,000 $108,000
Q1 2022 May 16, 2022	BUY	$1.44 - $5.22 $228,960 - $829,980	159,000 New	159,000 $235,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.